Skip to main content
  • Overview
    • News
    • Events & Presentations
    • Analyst Coverage
    • Filings
      • Quarterly Results
      • Annual Reports
      • SEC Filings
    • Governance
      • Governance Documents
      • Our Team
      • Committee Composition
    • Resources
      • Stock Quote
      • Investor Email Alerts
      • Investor & Media Contacts
Skip to main content
Viridian Therapeutics, Inc.

Governance Documents

  • Overview
    • News
    • Events & Presentations
    • Analyst Coverage
    • Filings
      • Quarterly Results
      • Annual Reports
      • SEC Filings
    • Governance
      • Governance Documents
      • Our Team
      • Committee Composition
    • Resources
      • Stock Quote
      • Investor Email Alerts
      • Investor & Media Contacts
Download item year list
Download Description
Corporate Governance Guidelines (opens in new window)
527 KB
Code of Business Conduct and Ethics (opens in new window)
311 KB
Audit Committee Charter (opens in new window)
359 KB
Compensation Committee Charter (opens in new window)
Nominating and Corporate Governance Committee Charter (opens in new window)
332 KB
Science and Technology Committee Charter (opens in new window)
140 KB

Quick Links

  • Viridian Therapeutics
  • SEC Filings
  • Events & Presentations
  • Quarterly Results

IR Contact

IR@viridiantherapeutics.com


Media Contact

Media@viridiantherapeutics.com

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Viridian Therapeutics, Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Viridian Therapeutics, Inc. to send you the requested Investor Email Alert updates.

* Required

*
Investor Alert Options
*





Unsubscribe

Email Alert Sign Up Confirmation

© 2023 Viridian Therapeutics, Inc. - All rights reserved
Powered By Q4 Inc. 5.156.1.1 (opens in new window)
  • Privacy Policy
  • Cookie Policy
  • Terms of Use
  • Site Map